Great Plains Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• ACC Scientific Statement Addresses DOACs in Primary and Secondary Prevention of Thrombotic Events
  Even with robust evidence demonstrating their efficacy and safety, direct oral anticoagulants (DOACs) continue to be underused and, at times, inappropriately dosed, particularly in patients at elevated thrombotic risk.
• ACC Scientific Statement Guides Use of Antiplatelet Therapy in Managing ASCVD
  A new ACC Scientific Statement focused on the management of atherosclerotic cardiovascular disease, aims to help clinicians overcome the perpetual challenge of balancing the risk of ischemia with the risk of bleeding in this patient population.
• Withdrawing vs. Continuing GDMT in Patients With Improved Cardiac Function Post AFib Ablation
  In patients with atrial fibrillation (AFib) with normal cardiac function and sinus rhythm after catheter ablation, 12% who discontinued guideline-directed medical therapy (GDMT) experienced heart failure (HF) deterioration, while drug-related complications were more likely among patients who continued GDMT...
• Discontinuation of Oral Anticoagulation After AF Catheter Ablation (ALONE-AF): ALONE, but Not the Only One
  The ALONE-AF (Anticoagulation One Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation) trial examined whether discontinuing oral anticoagulation (OAC) in patients with elevated stroke risk after catheter ablation of atrial fibrillation (AFCA) who remain free of atrial arrhythmias in the year after their indexed ablation leads to fewer adverse clinical outcomes.
• ACC CardiaCast: Understanding the Spectrum: Causes and Risks of HTG and sHTG
  This episode is part of ACC’s ongoing initiative to recognize the risks and tackle management of Hypertriglyceridemia (HTG) and Severe Hypertriglyceridemia (sHTG).